Trial Profile
Impact and Time Course of Colchicine Therapy on C-reactive Protein Elevation in Chronic Atrial Fibrillation (AF) and Post AF Ablation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Colchicine (Primary)
- Indications Atrial fibrillation
- Focus Pharmacodynamics
- 18 Apr 2019 Status changed from recruiting to completed.
- 24 Mar 2015 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 24 Feb 2014 Planned End Date changed from 1 Mar 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov record.